Emergent Biosolutions Inc (EBS) poses a Brand-New Opportunity for Investors with beta value of 1.60
Witnessing the stock’s movement on the chart, on Thursday, Emergent Biosolutions Inc (NYSE: EBS) set off with pace as it heaved 4.73% to $9.97, before